112 related articles for article (PubMed ID: 24050452)
1. Modified trastuzumab and cetuximab mediate efficient toxin delivery while retaining antibody-dependent cell-mediated cytotoxicity in target cells.
Gilabert-Oriol R; Thakur M; von Mallinckrodt B; Hug T; Wiesner B; Eichhorst J; Melzig MF; Fuchs H; Weng A
Mol Pharm; 2013 Nov; 10(11):4347-57. PubMed ID: 24050452
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial approach to increase efficacy of Cetuximab, Panitumumab and Trastuzumab by dianthin conjugation and co-application of SO1861.
Gilabert-Oriol R; Weng A; Trautner A; Weise C; Schmid D; Bhargava C; Niesler N; Wookey PJ; Fuchs H; Thakur M
Biochem Pharmacol; 2015 Oct; 97(3):247-55. PubMed ID: 26253687
[TBL] [Abstract][Full Text] [Related]
3. Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent.
Holmes SE; Bachran C; Fuchs H; Weng A; Melzig MF; Flavell SU; Flavell DJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):42-55. PubMed ID: 25347443
[TBL] [Abstract][Full Text] [Related]
4. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells.
Yip WL; Weyergang A; Berg K; Tønnesen HH; Selbo PK
Mol Pharm; 2007; 4(2):241-51. PubMed ID: 17263556
[TBL] [Abstract][Full Text] [Related]
5. Ablation of breast cancer cells using trastuzumab-functionalized multi-walled carbon nanotubes and trastuzumab-diphtheria toxin conjugate.
Oraki Kohshour M; Mirzaie S; Zeinali M; Amin M; Said Hakhamaneshi M; Jalili A; Mosaveri N; Jamalan M
Chem Biol Drug Des; 2014 Mar; 83(3):259-65. PubMed ID: 24118702
[TBL] [Abstract][Full Text] [Related]
6. Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-Immunotoxin.
Gilabert-Oriol R; Thakur M; Haussmann K; Niesler N; Bhargava C; Görick C; Fuchs H; Weng A
Planta Med; 2016 Dec; 82(18):1525-1531. PubMed ID: 27392242
[TBL] [Abstract][Full Text] [Related]
7. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
8. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure.
Bachran C; Sutherland M; Heisler I; Hebestreit P; Melzig MF; Fuchs H
Exp Biol Med (Maywood); 2006 Apr; 231(4):412-20. PubMed ID: 16565437
[TBL] [Abstract][Full Text] [Related]
9. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
10. Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.
Gianolio DA; Rouleau C; Bauta WE; Lovett D; Cantrell WR; Recio A; Wolstenholme-Hogg P; Busch M; Pan P; Stefano JE; Kramer HM; Goebel J; Krumbholz RD; Roth S; Schmid SM; Teicher BA
Cancer Chemother Pharmacol; 2012 Sep; 70(3):439-49. PubMed ID: 22821053
[TBL] [Abstract][Full Text] [Related]
11. Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cells.
Heisler I; Sutherland M; Bachran C; Hebestreit P; Schnitger A; Melzig MF; Fuchs H
J Control Release; 2005 Aug; 106(1-2):123-37. PubMed ID: 15935506
[TBL] [Abstract][Full Text] [Related]
12. Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells.
Polito L; Mercatelli D; Bortolotti M; Maiello S; Djemil A; Battelli MG; Bolognesi A
Toxins (Basel); 2017 May; 9(6):. PubMed ID: 28556822
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.
Smith WS; Johnston DA; Holmes SE; Wensley HJ; Flavell SU; Flavell DJ
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791598
[TBL] [Abstract][Full Text] [Related]
14. Small structural differences of targeted anti-tumor toxins result in strong variation of protein expression.
Gilabert-Oriol R; Thakur M; Weise C; Dernedde J; von Mallinckrodt B; Fuchs H; Weng A
Protein Expr Purif; 2013 Sep; 91(1):54-60. PubMed ID: 23867360
[TBL] [Abstract][Full Text] [Related]
15. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
16. Bridging disulfides for stable and defined antibody drug conjugates.
Badescu G; Bryant P; Bird M; Henseleit K; Swierkosz J; Parekh V; Tommasi R; Pawlisz E; Jurlewicz K; Farys M; Camper N; Sheng X; Fisher M; Grygorash R; Kyle A; Abhilash A; Frigerio M; Edwards J; Godwin A
Bioconjug Chem; 2014 Jun; 25(6):1124-36. PubMed ID: 24791606
[TBL] [Abstract][Full Text] [Related]
17. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
18. Saponins modulate the intracellular trafficking of protein toxins.
Weng A; Thakur M; von Mallinckrodt B; Beceren-Braun F; Gilabert-Oriol R; Wiesner B; Eichhorst J; Böttger S; Melzig MF; Fuchs H
J Control Release; 2012 Nov; 164(1):74-86. PubMed ID: 23063550
[TBL] [Abstract][Full Text] [Related]
19. Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs.
Garcia AG; Nedev H; Bijian K; Su J; Alaoui-Jamali MA; Saragovi HU
Oncogene; 2013 May; 32(20):2527-33. PubMed ID: 22797066
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]